|
Recent Publications (since 2003)
1. Miriagou V, Tzelepi E, Gianneli D, Tzouvelekis LS. Escherichia coli with a self-transferable, multi-resistant plasmid coding for the metallo-β-lactamase VIM-1. Antimicrobial Agents & Chemotherapy 2003, 47, 395-7.
2. Tzelepi E, Magana Ch, Platsouka E, Sofianou D, Paniara O, Legakis NJ, Vatopoulos AC, Tzouvelekis LS. Extended-spectrum β-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. International Journal of Antimicrobial Agents 2003, 21, 285-8.
3. Vourli S, Kartali G, Kontopoulou C, Sofianou D, Tzouvelekis LS, Tzelepi E. Characterization of Klebsiella pneumoniae clinical strains producing a rare extended-spectrum β-lactamase (IBC-1). International Journal of Antimicrobial Agents 2003, 21, 495-7.
4. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM. Imipenem resistance in a Salmonella clinical strain due to production of a plasmid-mediated class-A carbapenemase similar to KPC-1. Antimicrobial Agents & Chemotherapy 2003, 47, 1297-1300.
5. Giakkoupi P, Xanthaki A, Kanelopoulou M, Vlahaki A, Miriagou V, Kontou S, Papafraggas E, Malamou-Lada H, Tzouvelekis LS, Legakis NJ, Vatopoulos AC. VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. Journal of Clinical Microbiology 2003, 41, 3893-6.
6. Vourli S, Tzouvelekis LS, Tzelepi E, Lebessi E, Legakis NJ, Miriagou V. Characterization of In111, a class 1 integron that carries the extended-spectrum β-lactamase gene blaIBC-1. FEMS Microbiology Letters 2003, 225, 149-153.
7. Vourli S, Giakkoupi P, Miriagou V, Tzelepi E, Vatopoulos AC, Tzouvelekis LS. Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiology Letters 2004, 234, 209-213.
8. Miriagou V, Tzouvelekis LS, Villa L, Lebessi E, Vatopoulos AC, Carattoli A, Tzelepi E. CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid. Antimicrobial Agents & Chemotherapy 2004, 48, 3172-3174.
9. Lowndes CM & Kevin Fenton A, and the European Surveillance of Sexually Transmitted Infections (ESSTI) Network. Surveillance Systems for STIs in the European Union: Facing a changing epidemiology. Sexually Transmitted Infections 2004, 80, 264-271.
10. Fenton KA & Lowndes CM, and the European Surveillance of Sexually Transmitted Infections (ESSTI) Network. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sexually Transmitted Infections 2004, 80, 255-263.
11. Miriagou V, Tassios PT, Legakis NJ, Tzouvelekis LS. Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. International Journal of Antimicrobial Agents 2004, 23, 547-555.
12. Gangoue-Pieboji J, Miriagou V, Vourli S, Tzelepi E, Ngassam P, Tzouvelekis LS. Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element. Antimicrobial Agents & Chemotherapy 2005, 49, 441-443.
13. Giakkoupi P, Tzouvelekis LS, Daikos GL, Miriagou V, Petrikos G, Legakis NJ, Vatopoulos AC. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates. Journal of Clinical Microbiology 2005, 43, 494-496.
14. Miriagou V, Tzelepi E, Daikos G, Tassios P, Tzouvelekis LS. Panresistance in VIM-1 producing Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy 2005, 55, 810-811.
15. Miriagou V, Carattoli A, Tzelepi E, Villa L, Tzouvelekis LS. IS26-associated In4-type integrons forming multiresistant loci in enterobacterial plasmids. Antimicrobial Agents & Chemotherapy 2005, 49, 3541-3543.
16. Arthur G, Lowndes CM, Blackham J, Fenton KA, and the European Surveillance of Sexually Transmitted Infections (ESSTI) Network. Divergent approaches to partner notification for sexually transmitted infections across the European Union. Sexually Transmitted Diseases 2005, 32, 734-741.
17. Tzelepi E. Antibiotic resistance in Neisseria gonorrhoeae. In: Sexually Transmitted Diseases, Clinical Prep School Series, vol. 17 (issue 3), pp 91–115. Medical Society of Athens, Athens 2005. [in Greek]
18. Stathi M, Flemetakis A, Miriagou V, Kyriakis KP, Maniatis A, Tzelepi E. Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece. Data for the years 1994–2004. Journal of Antimicrobial Chemotherapy 2006, 57, 775-779.
19. Miriagou V, Carattoli A, Fanning S. Antimicrobial resistance islands: resistance gene clusters in Salmonella chromosome and plasmids. Microbes & Infection 2006, 8, 1923-1930. [Review]
20. Carattoli A, Miriagou V, Bertini A, Loli A, Colinon C, Villa L, Wichard JM, Rossolini G-M. Replicon typing of plasmids encoding resistance to newer β-lactams. Emerging Infectious Diseases 2006, 12 1145-1148.
21. Loli A, Tzouvelekis LS, Tzelepi E, Vatopoulos A, Tassios P, Miriagou V. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1. Journal of Antimicrobial Chemotherapy 2006, 58, 669-672.
22. Martin IMC, Hoffmann S and Ison CA on belhaf of the European Surveillance of Sexually Transmitted Infections (ESSTI) Network. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. Journal of Antimicrobial Chemotherapy 2006, 58, 587-593.
23. Ison CA, Martin IMC, Lowndes CM and Fenton KA on behalf of the European Surveillance of Sexually Transmitted Infections (ESSTI) Network. Comparability of laboratory duagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae from reference laboratories in Western Europe. Journal of Antimicrobial Chemotherapy 2006, 58, 580-586.
24. Daikos GL, Panagiotakopoulou A, Tzelepi E, Loli A, Tzouvelekis LS, Miriagou V. Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model. Clinical Microbiology & Infection 2007, 13, 202-205.
25. Cornaglia G, Akova M, Amicosante G, Canton R, Cauda R, Docquier J-D, Edelstein M, Frere J-M, Miklos F, Galleni M, Giamarellou H, Gniadkowski M, Koncan R, Libisch B, Luzzaro F, Miriagou V, Navarro F, Nordmann P, Pagani L, Peixe L, Poirel L, Souli M, Tacconelli E, Vatopoulos A, Rossolini G-M. Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. International Journal of Antimicrobial Agents 2007, 29, 280-388.
26. Panagiotakopoulou A, Daikos GL, Miriagou V, Loli A, Tzelepi E, Tzouvelekis LS. Comparative in vitro killing of carbapenems and azthreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. International Journal of Antimicrobial Agents 2007, 29, 360-362.
27. Papagiannitsis CC, Loli A, Tzouvelekis LS, Tzelepi E, Arlet G, Miriagou V. SCO-1, a novel plasmid-mediated class A β-lactamase with carbecillinase characteristics from Escherichia coli. Antimicrobial Agents and Chemotherapy 2007, 51, 2185-2188.
28. Miriagou V, Tzouvelekis LS, Flevari K, Tsakiri M, Douzinas EE. Providencia stuartii with VIM-1 metallo-β-lactamase. Journal of Antimicrobial Chemotherapy 2007, 60, 183-184.
29. Colinon C, Miriagou V, Carattoli A, Luzzaro F, Rossolini G-M. Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 β-lactamases. Journal of Antimicrobial Chemotherapy 2007, 60, 258-262.
30. Papagiannitsis CC, Tzouvelekis LS, Tzelepi E, Miriagou V. Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli. Antimicrobial Agents and Chemotherapy 2007, 51, 3763-7.
31. Loli A, Tzouvelekis LS, Gianneli D, Tzelepi E, Miriagou V. Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests. Antinicrobial Agents and Chemotherapy 2008, 52, 1894-1896.
32. Zioga A, Whichard JM, Joyce KJ, Tzelepi E, Tzouvelekis LS, Miriagou V. Evidence for chromosomal and plasmid location of CMY-2 cephalosporinase gene in Salmonella serotype Typhimurium. Journal of Antimicrobial Chemotherapy 2008, 61, 1389-1399.
33. Tzelepi E, Daniilidou M, Miriagou V, Siatravani E, Pavlidou E, Flemetakis A (2008). Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece. Journal of Antimicrobial Chemotherapy 2008, 61, in press.
Recent Awards (since 2003)
1. First Prize of the Amphiaraion Foundation For Chemotherapy in the 30th Annual Panhellenic Medical Congress (Athens, May 2004) for the work «Νovel GES/IBC β-lactamase types with carbapenemase activity in clinical strains of Enterobacteriaceae isolated in Greece», presented by S. Vourli, P. Giakkoupi, V. Miriagou, E. Tzelepi, A. Vatopoulos, and L.S. Tzouvelekis.
2. Third Prize of the Amphiaraion Foundation For Chemotherapy in the 31th Annual Panhellenic Medical Congress (Athens, May 2005) for the work «Investigation of plasmids–vectors of IBC VIM-1-type β-lactamases in clinical Enterobacterial strains isolated in Greek hospitals», presented by A. Loli, D. Gianneli, L.S. Tzouvelekis, A. Vatopoulos, E. Tzelepi, and V. Miriagou.
3. First Prize for Basic Research in the 32nd Annual Panhellenic Medical Congress (Athens, May 2006) for the work «Characterization of plasmids conferring resistance to cephalosporins. Contribution to the study of phylogenesis of CMY beta-lactamases », presented by A. Zioga, K. Papagiannitsis, A. Loli, M. Stathi, E. Tzelepi, P.Th. Tassios, L.S. Tzouvelekis, and V. Miriagou.
4. Second Prize For Applied Research in the 32nd Annual Panhellenic Medical Congress (Athens, May 2006) for the work «Surveillance of susceptibility to antibiotics in Nreisseria gonorrhoeae in Greece during the years 1994 – 2005. Dramatic increase of resistance to the newer quinolones», presented by M. Stathi, H. Avgerinou, V. Miriagou, A. Flemetakis, M. Daniilidou, K. Papagiannitsis, A. Zioga, K.P. Kyriakis, and E. Tzelepi.
5. Second Prize of the Amphiaraion Foundation For Chemotherapy in the 32nd Annual Panhellenic Medical Congress (Athens, May 2006) for the work «Evaluation of imipenem efficacy against Klebsiella pneumoniae strains producing metallo-β-lactamases in experimental infection in mice», presented by A. Panagiotakopoulou, G. Daikos, A. Loli, K. Papagiannitsis, A. Zioga, L. Tzouvelekis, E. Tzelepi, and V. Miriagou.
6. FIRST Prize for Basic Research in the 33rd Annual Panhellenic Medical Congress (Athens, May 2007) for the work «Characterization of β-lactamases, ECL-1 and ACC-1 from a clinical Escherichia coli isolate», presented by C. Papagiannitsis, A. Loli, E. Tzelepi, A. Zioga, LS Tzouvelekis, and V. Miriagou.
7. First Prize for Basic Research in the 34th Annual Panhellenic Medical Congress (Athens, May 2008) for the work «Evaluation of the strenght of a new type of promoter in class I integrons», presented by C. Papagiannitsis, L.S. Tzouvelekis, E. Tzelepi and V. Miriagou.
|